Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neon Therapeutics, Inc. (NTGN) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neon Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1694187.
Total stock buying since 2018: $5,040,000.
Total stock sales since 2018: $847,593.
Total stock option exercises since 2018: $149,997.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2020 | 0 | $0 | 345,433 | $762,237 | 0 | $0 |
2019 | 0 | $0 | 65,322 | $85,356 | 0 | $0 |
2018 | 315,000 | $5,040,000 | 0 | $0 | 36,109 | $149,997 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2020-03 | 0 | $0 | 345,433 | $762,237 | 0 | $0 |
2019-11 | 0 | $0 | 65,322 | $85,356 | 0 | $0 |
2018-08 | 0 | $0 | 0 | $0 | 18,868 | $50,000 |
2018-07 | 0 | $0 | 0 | $0 | 17,241 | $99,997 |
2018-06 | 315,000 | $5,040,000 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-03-24 | Blavatnik Len (Other) | Sale | 201,686 | 2.20 | 443,104 |
2020-03-23 | Blavatnik Len (Other) | Sale | 50,358 | 2.17 | 109,478 |
2020-03-20 | Blavatnik Len (Other) | Sale | 84,339 | 2.22 | 186,895 |
2020-03-19 | Blavatnik Len (Other) | Sale | 9,050 | 2.52 | 22,760 |
2019-11-27 | Gaynor Richard (President of R&D) | Sale | 22,322 | 1.24 | 27,634 |
2019-11-26 | Gaynor Richard (President of R&D) | Sale | 23,000 | 1.31 | 30,222 |
2019-11-25 | Gaynor Richard (President of R&D) | Sale | 20,000 | 1.38 | 27,500 |
2018-08-20 | O'dowd Hugh (President & CEO) | Option Ex | 18,868 | 2.65 | 50,000 |
2018-07-17 | Al-wakeel Yasir B. (Chief Financial Officer) | Option Ex | 17,241 | 5.80 | 99,997 |
2018-06-29 | Blavatnik Len (Other) | Buy | 315,000 | 16.00 | 5,040,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of NTGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neon Therapeutics, Inc. (symbol NTGN, CIK number 1694187) see the Securities and Exchange Commission (SEC) website.